Association between the Endothelial Activation and Stress Index and Hearing Loss: A Cross-Sectional Analysis Based on the National Health and Nutrition Examination Survey (NHANES) 2015-2018
DOI:
https://doi.org/10.54097/4a2v2z47Keywords:
Endothelial Activation and Stress Index, Hearing Loss, NHANES, Cross-sectional Study, BiomarkerAbstract
Purpose: To investigate the association between the endothelial activation and stress index (EASIX) and hearing loss (HL), and to further analyze its dose–response relationship and differences across subgroups. Methods: Data were obtained from the 2015–2016 and 2017–2018 cycles of the National Health and Nutrition Examination Survey (NHANES), and a total of 5,707 participants with completed audiometric examinations and complete laboratory data were included. EASIX was calculated as LDH (U/L) × Cr (mg/dL) / PLT (10⁹/L). Hearing loss was defined as a pure-tone average (PTA) ≥ 25 dB HL at seven frequencies (0.5, 1, 2, 3, 4, 6, and 8 kHz) in the worse ear; low-frequency hearing loss (LFHL) and high-frequency hearing loss (HFHL) were defined using 0.5–2 kHz and 3–8 kHz, respectively. Multivariable linear regression and logistic regression were used to analyze the associations of EASIX with hearing thresholds and the risk of hearing loss, and generalized additive models were used to explore dose–response relationships. Results: In the fully adjusted model, participants in the highest EASIX quartile (Q4) had an average hearing threshold 5.3 dB HL higher than those in the lowest quartile (Q1) (β = 5.3, 95% CI 3.9–6.6, P < 0.001). Consistent with this finding, the Q4 group also showed a 2.6-fold higher risk of high-frequency hearing loss (HFHL) compared with the Q1 group (OR = 2.6, 95% CI 2.0–3.5, P < 0.001), along with a significantly elevated risk of low-frequency hearing loss (LFHL) (OR = 1.7, 95% CI 1.1–2.6, P = 0.026). Further dose–response analysis revealed a nonlinear relationship between EASIX and hearing threshold, with a breakpoint at approximately 1.12. In addition, subgroup analyses indicated that age, sex, diabetes, and hypertension each modified the association (all P for interaction < 0.01), with the strongest effects observed among participants without diabetes or hypertension. Conclusion: EASIX was positively associated with hearing loss, and the relationship was most evident in participants without diabetes or hypertension. As a simple, inexpensive composite measure of endothelial dysfunction, EASIX may help flag people at elevated risk of hearing loss.
Downloads
References
[1] Chadha, S., Kamenov, K., & Cieza, A. (2021). The world report on hearing. Bulletin of the World Health Organization, 99(4), 242–242A. https://doi.org/10.2471/BLT.21.285643. DOI: https://doi.org/10.2471/BLT.21.285643
[2] Murillo-Cuesta, S., et al. (2025). NLRP3 inflammasome and hearing loss: from mechanisms to therapies. Journal of Neuroinflammation, 22(1), 225. https://doi.org/10.1186/s12974-025-03482-0. DOI: https://doi.org/10.1186/s12974-025-03561-w
[3] Kalicińska, E., et al. (2021). Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study. Journal of Clinical Medicine, 10(19). https://doi.org/10.3390/jcm10194470. DOI: https://doi.org/10.3390/jcm10194373
[4] Mariotti, J., et al. (2023). EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide. Bone Marrow Transplantation, 58(3), 247–256. https://doi.org/10.1038/s41409-022-01872-0. DOI: https://doi.org/10.1038/s41409-022-01874-5
[5] Estler, B., et al. (2025). Endothelial dysfunction assessed by the endothelial activation and stress index (EASIX) predicts risk of mortality in chronic heart failure patients. International Journal of Cardiology, 438, 133566. https://doi.org/10.1016/j.ijcard.2025.133566. DOI: https://doi.org/10.1016/j.ijcard.2025.133566
[6] Makris, M., et al. (2026). Prognostic Role of the Endothelial Activation and Stress Index (EASIX) in Functional Outcomes and Mortality After Acute Ischemic Stroke: A Retrospective Pilot Cohort Study. Journal of Cardiovascular Development and Disease, 13(2). https://doi.org/10.3390/jcdd13020048. DOI: https://doi.org/10.3390/jcdd13020066
[7] Xu, H. B., et al. (2023). Association Between Endothelial Activation and Stress Index and 28-Day Mortality in Septic ICU patients: a Retrospective Cohort Study. International Journal of Medical Sciences, 20(9), 1165–1173. https://doi.org/10.7150/ijms.83092. DOI: https://doi.org/10.7150/ijms.85870
[8] Lo, J., et al. (2022). EAST/SeSAME Syndrome and Beyond: The Spectrum of Kir4.1- and Kir5.1-Associated Channelopathies. Frontiers in Physiology, 13, 852674. https://doi.org/10.3389/fphys.2022.852674. DOI: https://doi.org/10.3389/fphys.2022.852674
[9] Coppola, M. A., et al. (2023). Small Molecules Targeting Kidney ClC-K Chloride Channels: Applications in Rare Tubulopathies and Common Cardiovascular Diseases. Biomolecules, 13(4). https://doi.org/10.3390/biom13040632. DOI: https://doi.org/10.3390/biom13040710
[10] Cavallaro, G., et al. (2023). Endothelial Dysfunction and Metabolic Disorders in Patients with Sudden Sensorineural Hearing Loss. Medicina (Kaunas), 59(10). https://doi.org/10.3390/medicina59101761. DOI: https://doi.org/10.3390/medicina59101718
[11] Frosolini, A., et al. (2022). Digging into the Role of Inflammatory Biomarkers in Sudden Sensorineural Hearing Loss Diagnosis and Prognosis: A Systematic Review and Meta-Analysis. Medicina (Kaunas), 58(7). https://doi.org/10.3390/medicina58070930. DOI: https://doi.org/10.3390/medicina58070963
[12] Ni, W., Song, S. P., & Jiang, Y. D. (2021). Association between routine hematological parameters and sudden sensorineural hearing loss: A meta-analysis. Journal of Otology, 16(1), 47–54. https://doi.org/10.1016/j.joto.2020.12.001. DOI: https://doi.org/10.1016/j.joto.2020.07.006
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

